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Abstract
Purpose Many apparent differences exist in aetiology, genet-
ics, anatomy and treatment response between colon cancer
(CC) and rectal cancer (RC). This study examines the differ-
ences in patient characteristics, prevalence of complications
and their effect on short-term survival, long-term survival and
the rate of recurrence between RC and CC.
Methods For all stage II–III CC and RC patients who
underwent resection with curative intent (2006–2008) in
five hospitals in the Netherlands, occurrence of complica-
tions, crude survival, relative survival and recurrence rates
were compared.
Results A total of 767 CC and 272 RC patients underwent
resection. Significant differences were found for age, gender,
emergency surgery, T-stage and grade. CC patients experi-
enced fewer complications compared to RC (p = 0.019), but
CC patients had worse short-term mortality rates (1.5 versus
6.7 % for 30-day mortality, p = 0.001 and 5.2 versus 9.5 % for
90-day mortality, p = 0.032). The adjusted HR (overall sur-
vival) for CC patients with complications was 1.57 (1.23–
2.01; p < 0.001) as compared to patients without complica-
tions; for RC, the HR was 1.79 (1.12–2.87; p = 0.015).
Relative survival analyses showed high excess mortality in
the first months after surgery and a sustained, prolonged neg-
ative effect on both CC and RC. Complications were associ-
ated with a higher recurrence rate for both CC and RC; adjust-
ed analyses showed a trend towards a significant association.
Conclusion Large differences exist in patient characteristics
and clinical outcomes between CC and RC. CC patients have
a significantly higher short-term mortality compared to RC
patients due to a more severe effect of complications.
Keywords Colon cancer . Rectal cancer . Short-term
mortality . Complications . Recurrence . Failure-to-rescue
Introduction
Beart et al. (1983) and Bufill et al. (1990) were among the first
to show clinical and morphological differences between colon
cancer (CC) and rectal cancer (RC) over two decades ago.
Many studies have since supported this Btwo types of
CRC’s^ hypothesis, consequently resulting in a more defini-
tive separation of the colorectal cancer (CRC) group for sci-
entific research and treatment. However, many clinical conse-
quences are still not fully understood [1].
Accumulating evidence suggests etiological differences be-
tween CC and RC. Various studies indicate that high body
mass index, low physical activity and dietary parameters such
as high intake of beef, pork or lamb, processed meat and
alcohol are risk factors for CC but not for RC [2–4]. The
prevalence of genetic mutations or mutation patterns and he-
reditary cancer types seem to vary between CC and RC [2].
For CC, K-RAS mutations are thought to be a common early
event in carcinogenesis, but are much rarer in RC. RC has
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more immunohistochemical expression of p53, which has a
yet unexplained positive correlation with the patients’ age and
is of independent prognostic value for the disease free surviv-
al, in contrast to CC p53 mutations [5]. Furthermore, HNPCC
is associated with right-sided CC whilst FAP is associated
with left-sided (or distal) CC and RC (also known as left-
sided CRC) [1].
Anatomically, the colon and rectum are very different in
location, blood supply, drainage and innervation. These dif-
ferences result in dissimilarities in the invasive growth of the
primary tumour as well as surgical approaches and treatment
outcomes [6]. They are also grounded for differences in the
mechanisms for developing recurrences and metastases [7].
The rectal venous drainage bypasses the liver, which explains
a higher frequency of lung and bone metastases in RC.
Peritoneal spread is much more frequent in colon cancer,
which is due to the location of the colon in the peritoneal
cavity whilst the rectum is located in the pelvis. Different
organ metastases have varying thymidylate synthase expres-
sion levels that result in differences in the chemosensitivity of
metastases between RC and CC [7–9]. Postoperative
fluorouracil-based (5-FU) chemotherapy is successful for
CC (especially proximal/right-sided tumours), but its effect
on the (disease free) survival of RC patients is still much
debated [9, 10]. Besides the anatomical explanations, the mi-
crosatellite instability and CpG island methylator phenotypes
being associated with proximal (or right-sided) CC and chro-
mosomal instability with distal CC and RC is of importance
for the chemosensitivity [10].
Other differences in the response to treatments includes
preoperative radiotherapy, which reduces recurrence and is
favourable for the survival of RC stage II and III patients
whilst this is less evident in CC, also because of a poorly
defined target due to the colon’s mobility, and dose-limiting
structures in its proximity [11].
The primary treatment for both CC and RC is surgical
resection. Resection for both cancer surgeries is considered
to be high-risk surgery, with significant morbidity and mortal-
ity. Postoperative mortality rates are about 5 % and complica-
tion rates range from 20 to 40 % [12–14]. Postoperative com-
plications (such as anastomotic leakage) are associated with
mortality due to their association with local recurrences and a
prolonged effect of the impact of the surgery, reflected by the
1-year excess mortality rates [12, 15]. The 1-year excess mor-
tality rates vary largely between CC and RC patients. Gooiker
et al. (2012) showed 1-year excess mortality rates of 10.9 %
for CC patients versus 4.8 % for RC patients [12].
The identification and separation of CC and RC as different
malignancies have already allowed for better-targeted and
specified treatment. Increasing our understanding of funda-
mental differences between CC and RC and their pathogenesis
even further enables improvement of the prognostic accuracy,
treatments and patient care.
From a clinical perspective, it is important to be aware of
differences in patient characteristics and in surgical outcomes
between CC and RC patients. The aim of this study is to
identify differences between CC and RC with the emphasis
on differences in short-term survival, complications and the
effect on recurrences.
Patients and methods
All CC and RC stage II and III patients diagnosed be-
tween 2006 and 2008 in the Leiden region of the
Netherlands Comprehensive Cancer Organisation (IKNL)
who received curative surgery were selected from the
Netherlands Cancer Registry (NCR). Data managers col-
lected data from the original patient files in one academic
and four teaching hospitals: Leiden University Medical
Centre (LUMC), HAGA hospital, Medical Centre
Haaglanden (MCH), Reinier de Graaf Group (RdGG)
and Groene Hart Hospital (GHZ). The data collected in-
cluded information on the diagnosis, staging, surgery,
complications (such as ileus, anastomotic leakage and car-
diac or respiratory events), patient characteristics, comor-
bidities, follow-up time and recurrences. Exclusion
criteria included previous colorectal tumours in the pa-
tient’s history (n = 6), incorrect staging or incomplete
TNM-scores (n = 52) and missing data on recurrences or
the survival parameters (n = 13). CC was defined as ma-
lignancies located from caecum to sigmoid and RC was
defined as malignancies located in the rectum, a tumour
within 15 cm from the anal verge. All patients with
rectosigmoid tumours were also excluded (n = 144).
Statistical analysis
All statistical analyses were performed using IBM SPSS
statistics software version 20.0 and STATA version 12.0.
The significance of differences in the patient characteris-
t ics was calculated using the Chi-squared test .
Relationships between complications and the overall sur-
vival (OS) as well as the disease free period (DFP) were
assessed for CC and RC patients. All time-to-event vari-
ables were calculated from date of surgery. An event for
the OS was defined as death due to any cause; for the
DFP, any recurrence (locoregional and distant) was de-
fined as an event. Univariate and multivariable Cox pro-
portional Hazard models were used to model the impact
of complications on the OS and DFP with adjustments for
age, stage, grade and emergency surgery. Short-term mor-
tality was calculated as a percentage of mortality due to
any cause. Expected mortality was based on the matched
(age, sex, year) general population. Relative survival was
calculated as the ratio of the survival observed among the
1684 Int J Colorectal Dis (2016) 31:1683–1691
cancer patients and the survival that would have been
expected based on the corresponding, age, sex and year-
matched, general population. National life tables were
used to estimate expected survival (Ederer II method).
Relative excess risks of death (RER) were calculated for
the differences between colon and rectal cancer using a
multivariable generalized linear model with a Poisson dis-
tribution, based on collapsed relative survival data, using
exact survival times. A p value below 0.05 was consid-
ered statistically significant.
Results
Between 2006 and 2008, 767 CC patients and 272 RC
patients with stage I, II and III disease were operated with
curative intent. Surgery was performed using convention-
al laparoscopic or laparotomic resection techniques. Pre
and postoperative radio-/chemotherapy was administered
to qualifying RC and CC patients conform the Dutch
BGuidelines of Oncological Health^ [16]. The median
age of these patients was 72 years (range 25–96 years)
for colon and 69 years (range 30–94 years) for rectal
cancer. Patient characteristics are shown in Table 1.
Significant differences between colon and rectum patients
were observed in most characteristics. With respect to
patient characteristics, more male patients had rectal can-
cer (47.8 % for colon versus 58.8 % for rectal cancer). Of
all CC patients, 45.4 % was above the age of 75, versus
31.6 % of the RC patients. Comorbidities were signifi-
cantly more common in CC patients (76.3 versus 68.8 %
in RC patients) and emergency surgeries were also more
common in CC patients (14.0 %) than RC patients
(0.7 %). In addition, differences in T-stage, grade and
pre/postoperative adjuvant treatments were observed.
Short-term mortality
As shown in Table 2, there was a difference in the short-term
(observed) mortality of 5.2 % (6.7 % for CC and 1.5 % for
RC; p = 0.001) between CC and RC patients after 30 days.
This difference was also evident in the 90-day mortality (with
a difference of 4.3 %, p = 0.032), but was no longer significant
for the 1-year observed mortality (difference of 4.5 %,
p = 0.075). The proportion of one-year excess mortality is
higher for CC (12.5 and 8.5 %), however, not statistically
significant (p = 0.1). When adjusted for age, T-stage, grade,
surgery in emergency setting, comorbidity and number of
complications, there was no difference in 1-year mortality
between colon and rectal cancer (odds ratio 1.01 (95 % con-
fidence interval (CI) 0.60–1.66); p = 0.8).
Long-term relative survival and recurrences
The median follow-up time for all patients was 3.5 years
(range 0.0–7.0 years). The relative survival (Fig. 1 top
graph) for CC shows a steep decline in the cumulative
relative survival in the first period after surgery. This de-
cline is absent in the RC patient group. The observed dif-
ference in the relative survival between CC and RC yielded
a RER of 1.58 (95 % Cl 0.98–2.53); p = 0.059. There were
no significant differences in the cumulative recurrence rate
for CC and RC patients (hazard ratio (HR) 0.90, (95 % Cl
0.67–1.18); p = 0.4, Fig. 1 bottom graph).
Complications
CC patients experienced fewer complications compared to RC
patients (41.1 versus 49.3 %; p = 0.019). The most common
complications were similar for CC and RC: anastomotic leak-
ages, ileus, cardiac events and respiratory tract infections. Of
all CC patients, 20.3 % experienced surgical complications
and 23.4 % medical complications, compared to 25.3 % sur-
gical complications for RC patients and 22.3 % medical com-
plications [17]. Table 3 shows the number of patients with
postoperative complications and their association with surviv-
al and recurrences, stratified for colon and rectal cancer.
The 5-year overall survival for patients with complications
with RC was higher than for CC patients, 56.6 % (45.5–66.3)
versus 49.7 % (43.4–55.7), respectively. Differences in 5-year
overall survival for patients with and without complications
were significant for both CC and RC patients. The adjusted
HR for CC patients was 1.57 (1.23–2.01; p < 0.001) and for
RC the HR was 1.79 (1.12–2.87; p = 0.015).
The adjusted differences in the DFP between patients
with and without complications showed a trend towards
significance for both CC and RC patients with an adjusted
HR of 1.29 (0.99–1.80; p = 0.1) and 1.43 (0.86–2.39;
p = 0.2), respectively.
Figure 2 shows the overall survival and disease free
period for CC and RC patients with and without compli-
cations. Differences in the OS between the patients with
and without complications were statistically significant;
p < 0.001 for CC and p = 0.002 for CR. There is also a
significant difference in the overall survival between CC
and RC patients with complications (p = 0.029), whilst
the difference shows a trend towards significance between
CC and RC patients without complications (p = 0.074).
The figure shows a high mortality rate in the short-term
postoperative period (30 days) for CC patients. The DFP
curve shows a statistical trend towards a higher recurrence
rate in the CC and RC groups with complications
(p = 0.104 and 0.204 for CC patients or CR patients with
and without complications, respectively).
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Table 1 Patient characteristic,
according to colon or rectal
cancer
Characteristics Colon, N = 767
(73.8 %)
Rectum, N = 272
(26.2 %)
P value
Gender Male 367 (47.8) 160 (58.8) 0.002
Female 400 (52.2) 112 (41.2)
Age <65 206 (26.9) 92 (33.8) <0.001
65–75 213 (27.8) 94 (34.6)
>75 348 (45.4) 86 (31.6)
Comorbidity Yes 585 (76.3) 187 (68.8) 0.015
No 182 (23.7) 85 (31.2)
Number of comorbidities None 85 (31.3) 182 (23.7) 0.04
1 72 (26.5) 203 (26.5)
2 56 (20.6) 159 (20.7)
>2 59 (21.7) 223 (29.1)
ASA score I 78 (10.2) 34 (12.5) 0.02
II 228 (29.7) 98 (36.0)
III 102 (13.3) 17 (6.3)
IV 7 (0.9) 2 (0.7)
V 2 (0.3) 1 (0.4)
Emergency 7 (0.9) 0 (0.0)
Unknown 343 (44.7) 120 (44.1)
TNM-stage II 486 (63.4) 178 (65.4) 0.5
III 281 (36.6) 94 (34.6)
T-stage T1 46 (6.0) 18 (6.6) <0.001
T2 142 (18.5) 99 (36.4)
T3 492 (64.2) 151 (55.5)
T4 87 (11.3) 4 (1.5)
Grade 1 47 (6.1) 5 (1.8) <0.001
2 500 (65.2) 123 (45.2)
3 112 (14.6) 20 (7.4)
Unknown 108 (14.1) 124 (45.6)
Emergency Yes 107 (14.0) 2 (0.7) <0.001
No 660 (86.0) 270 (99.3)
Table 2 Short-term mortality
rates and survival for colon and
rectal cancer patients
Rectal cancer Colon cancer p value
30-day observed mortalitya 1.5 6.7 0.001
90-day observed mortalitya 5.2 9.5 0.032
1-year observed mortalitya 11.6 16.1 0.075
1-year expected mortalityb 3.1 3.6 –
Excess mortality 8.5 12.5 0.1
Multivariable analyses of the 1-year mortalityc OR 1.01 (0.60–1.66) 0.8
The italicized items have a p - value smaller than 0.05, which is considered statistically significant in our study
aOverall mortality due to any cause
b Expected mortality based on the matched (age, sex, year) general population
c Adjusted for age, T-stage, grade, emergency setting, comorbidity and number of complications OR odds ratio
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Discussion
In this study, a large difference has been observed in the
short-term mortality of RC and CC patients with a higher
mortality for patients with colon cancer. Patients with rec-
tal cancer experience complications more often after sur-
gery. Stratified by CC and RC, complications are associ-
ated with a worse overall survival, however not with re-
currences. Patients with colon cancer and complications
after surgery have the worst survival, compared to rectal
cancer patients and patients without complications.
Age and gender
The proportion of males was higher for RC than for CC. This
can partly be explained by the age difference between RC and
CC patients; RC patients are evenly distributed among the age
groups, whilst many of the CC patients are older than 75 years.
This unequal gender distribution at high age due to the differ-
ence in lifespan is also shown in other studies [12, 15]. This
suggests CC to be a more age-related disease than RC and
indicates the two malignancies must have different aetiologies
[2–5, 18]. Old age is known to have a negative effect on the
recovery of surgery for CC patients. Many studies found age
to be a significant predictor of more complications and higher
short-term mortality in colon and rectal cancer, more specific
for medical complications but not for surgical complications
[13, 19–22].
Complications
Our analyses on complications revealed discrepancies in the
prevalence and in the short-term effects of complications on
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patients. Of all RC patients, 49.3 % experienced complica-
tions versus 41.1 % of CC patients. Reported percentages in
literature of colorectal postoperative complications include
46.5 % by Biondo et al. (2004) and 23%major complications
by Al-refaie et al. (2011) [13, 19]. Iversen et al. (2008) noted a
frequency of 27.8 % for surgical complications, and Marusch
et al. (2005) 20 %, which are similar to our results [20, 21].
Law et al. (2007) and McArdle et al. (2005) also reported that
medical complications are more common in CC patients
whilst surgical complications are more common in RC pa-
tients [23, 24].
The effect of surgery and surgical complications on patient
mortality is known to increase with age. Elderly are not only
more prone to suffer from complications, they are also more
likely to succumb to them [25, 26].
Short-term mortality
The short-term survival of CC patients is worse than that of
RC patients due to more excess mortality in the first few
months after surgery. Short-term excess mortality rates of
CC are 12.5 % versus a much lower 8.5 % for RC after 1 year.
These findings are in line with the overall 1-year excess mor-
tality rates of 10.9 % for CC patients versus 4.8 %
for RC patients reported by Gooiker et al. (2012) [12]. The
large difference visible in the first few months of the relative
survival between RC and CC confirms this observation.
Relative survival was used to correct for the overestimation
of the effect of cancer on survival [15]. Crude survival
reflects the mortality rates regardless of cause, whilst relative
survival is defined as the ratio of observed versus expected
mortality, which is valuable with large age differences
within the patient population. Utilizing these figures to
compute the relative excess risk also enables a more accurate
comparison of the effects of surgery on RC and CC
patients. The relative survival differences were borderline
significant.
Complications had a negative effect on the overall survival
of both rectal cancer and colon cancer patients. However, the
short-term effects of complications were worse for CC pa-
tients, and accounts for the large differences in 1-year excess
mortality between RC and CC. The discrepancy in the effect
of complications on survival, together with the discrepancy in
the prevalence of complications is described as the failure-to-
rescue difference between colon- and rectal cancer complica-
tions [26]. The study by Henneman et al. (2014) demonstrates
that factors such as age, ASA-status, comorbidity and colon-
or rectum-resections are of significant influence on the failure-
to-rescue in colorectal cancer, whilst factors such as TNM-
stage, neo-adjuvant therapy or approach (laparoscopy/laparot-
omy) are not.
Long-term survival and recurrences
The overall survival differences for patients with and without
complications remained after adjusting for both RC and CC
Table 3 Proportion of complications and the association with overall survival (OS) and disease free period (DFP)
Complications Colon cancer Rectal cancer P value
Complications Yes 315 (41.1) 134 (49.3) 0.019
No 452 (58.9) 138 (50.7)
Association complications and overall survival (OS)
5-years OS HR (95%CI) p value Adjusteda HR (95%CI) p value
Complications in No 68.3 (62.9–73.0) 1.0 (ref) <0.001 1.0 (ref) <0.001
colon cancer patients Yes 49.7 (43.4–55.7) 2.02 (1.59–2.55) 1.57 (1.23–2.01)
Complications in No 77.4 (69.7–84.0) 1.0 (ref) 0.002 1.0 (ref) 0.015
rectal cancer patients Yes 56.6 (45.5–66.3) 2.04 (1.29–3.22) 1.79 (1.12–2.87)
Association complications and disease free period (DFP)
5-years DFP HR (95%CI) p value Adjusteda HR (95%CI) p value
Complications in No 77.8 (73.3–81.6) 1.0 (ref) 0.1 1.0 (ref) 0.1
colon cancer patients Yes 71.2 (64.8–76.7) 1.30 (0.95–1.79) 1.29 (0.93–1.80)
Complications in No 75.8 (67.2–82.5) 1.0 (ref) 0.2 1.0 (ref) 0.2
rectal cancer patients Yes 64.4 (53.4–73.4) 1.36 (0.84–2.21) 1.43 (0.86–2.39)
The table shows the cumulative proportion surviving 5 years after surgery, the cumulative proportion surviving disease free 5 years after surgery, the
related hazard ratios and adjusted hazard ratios
The italicized items have a p - value smaller than 0.05, which is concidered statistically significant in our study
OS overall survival, DFP disease free period, HR hazard ratio, Ref reference category
a Adjusted for age, T-stage, grade and emergency setting
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patients, with a worse survival rate for patients with compli-
cations. Complications in CC and RC patients result in a stable
long-term increased mortality rate for as long as the follow-up
was recorded in this study (up to 7 years). These results cor-
respond with those found by Dekker et al. (2011) [15].
A statistical trend was found towards a worse disease free
period in the CC and RC groups with complications. Systemic
mechanisms such as the immune system, which has signifi-
cant influence on the tumour progression for colorectal and
breast-cancer, could explain both the occurrence of multiple
complications and susceptibility to recurrences [27, 28].
Moreover, postoperative infectious complications could lead
to an increase of systemic cytokines by the activated immune
system. These cytokines, also associated with wound-healing,
reduce anti-antigenic factors and act as growth factors, thus
stimulating tumour-cell growth and proliferation of circulating
micro-metastases [29]. Prolonged decreased mobility, associ-
ated with complications has also been revealed to affect intes-
tinal transit time, levels of insulin-like growth factors and the
immune system [30]. In stage III, CC complications lead to a
delayed start of chemotherapy, which is associated with a
worse disease free and overall survival [31]. More detailed
analyses in future studies on the type of postoperative compli-
cations or histopathological analysis on the lymphocytic infil-
tration of the tumour tissue could provide more clarity on this
matter. Such knowledge could improve the prognostic accu-
racy and might allow for patient specific selection for chemo-
therapy treatment.
Limitations
Limitations inherent to the retrospective design apply to
our study. The preoperative period of neoadjuvant chemo
and/or radiotherapy, usually more frequent in RC, could
form a selection period to surgery. Furthermore our study
lacks detail on the impact of different types of complica-
tions as well as the effect of age on the incidence and
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these topics could reveal more about the nature of the
discrepancy in the frequency and effect of complications.
Patients with the primary tumour located in the
rectosigmoid were excluded due to the uncertain nature of
these malignancies. Crude analyses including this group indi-
cated they are clinically more similar to RC patients than to
CC patients, and classifying them as such enhanced the statis-
tical differences between CC and RC.
Colon and rectal cancer patients have a different age distri-
bution, and previous studies show the importance of age on
survival and the risk for and impact of complications [13,
19–22, 25, 26]. However, no studies have been conducted
which compare the effects of complications for different age
groups and with colon and rectal cancer analysed separately.
Such study would provide more insight into the effect of age
on the development and severity of complications, which we
have proven to be very different for colon and rectal cancer,
and could also explain the difference in the failure-to-rescue.
The proportion of patients with more advanced stage
(T4) and the proportion of patients treated in an emergen-
cy setting were larger for colon cancer patients. These
factors are associated with complications, overall survival
and recurrences. Although we adjusted for these factors in
the multivariable analyses, some residual confounding
might be present due to other factors associated with more
advanced stage and emergency setting which we could
not adjust for in the analyses. Grade was also distributed
differently between colon and rectal cancer, however not
associated with the outcome in the present study.
A population-based screening program was initiated in the
Netherlands for both males and females in the age of 55 to
75 years old, which will likely increase the incidence of low
stage CC. This might results in a change in the discrepancies
between CC and RC patients. However, it is too early to esti-
mate these changes.
Conclusion
This study enucleates some of the epidemiological differences
and outcomes of colon and rectal cancer surgery which are of
clinically relevant prognostic value. Short-term mortality is
higher for patients with colon cancer, especially those who
experience complications, although this was not associated
with recurrences. Detailed analyses of factors leading to and
prevention of complications should be the focus to improve
the short-term outcomes of patients with colon cancer.
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